With an annual revenue exceeding €170 million and more than 500 employees across 4 European countries, we work with many of the world’s leading medical device companies and help them drive growth and achieve quicker, more efficient routes to market though existing and new channels.
We supply world-class training for the world’s leading healthcare products and provide state-of-the-art distribution and logistics, and asset tracking with speed and accuracy in mind so our partners are always fully aware of their product’s journey in the supply chain and can rest assured delivery is safe, transparent and fully accountable.
In addition, our in-depth knowledge of the medical landscape and of our clients’ technologies underpins our unrivalled technical support services.
With nearly 100 of the world’s leading healthcare companies choosing us to manage their portfolio, it is no surprise we have dedicated and specialist sales teams that focus wholly upon one product range. There is no crossover, so our teams become an extension of our partners’ operations, and experts in that particular field.
Over the past two decades we have continually grown the business through a combination of organic growth of existing product portfolios, entry into new geographical markets and by means of acquisition, most notably Aquilant Ltd in 2018, Xograph in 2019 and Cardio Solutions in 2020. This growth, and dedication to working with the key partners and OEM’s underlines our commitment to give partners and patients the best possible results.
Healthcare 21 Group exists to improve and support healthcare outcomes and customer relationships through our partners’ innovative products, services and solutions. We strive to assist clinicians, nursing and professional practitioners, patients, and clients in achieving optimal clinical results that enhance the quality of patient care and outcomes.
Owen Curtin, Chairman of HC21 Group